Contagion

Catharine Paddock PhD - 29 August 2014 - medicalnewstoday.com

An international research team has rapidly sequenced 99 Ebola virus genomes collected in the 2014 outbreak. The team, including members from the Broad Institute and Harvard University in the US and the Sierra Leone Ministry of Health and Sanitation, hopes the findings will help multidisciplinary, international efforts to understand and contain the unprecedented epidemic that is growing in West Africa.

The researchers report their findings in the journal Science. Five team members died of Ebola virus disease before the manuscript was published, and their fellow authors honor their memory in the study report.

The 99 genomes came from 78 patients diagnosed with Ebola virus disease in Sierra Leone during the first 24 days of the outbreak. Some patients gave more than one sample, allowing the team to see how the virus changed over the course of a single infection.

On the move: This model of West African regional transportation patterns was built using, among other sources, mobile-phone data for Senegal, released by the mobile carrier Orange.

Mobility data from an African mobile-phone carrier could help researchers recommend where to focus health-care efforts.

By David Talbot on August 22, 2014

BBC News - 28 August 2014 Last updated at 12:02 GMT

Nigeria has confirmed its first Ebola death outside Lagos – a doctor in the oil hub of Port Harcourt.  His wife has been put under quarantine, while a further 70 people in the city are under surveillance.  Latest figures show more than 1,550 people have died of Ebola, with at least 3,000 confirmed cases - mostly in Guinea, Liberia and Sierra Leone.  The World Health Organization (WHO) estimates that the total number of cases could potentially exceed 20,000.

http://www.bbc.com/news/world-africa-28966258

cell.com - medicinenet.com - nlm.nih.gov - theramatch.com

WEDNESDAY, Aug. 13, 2014 (HealthDay News) -- Researchers say they've discovered how the deadly Ebola virus disables the immune system. They hope the findings will prove valuable in efforts to find treatments for the disease taking hundreds of lives in Africa. . .

. . . American researchers found that the Ebola protein VP24 disrupts a cell's natural immune response. They said this action is an important first step on Ebola's path to causing fatal disease, according to the study published Aug. 13 in the journal Cell Host & Microbe.

(READ COMPLETE ARTICLE)

CLICK HERE - STUDY - Ebola Virus VP24 Targets a Unique NLS Binding Site on Karyopherin Alpha 5 to Selectively Compete with Nuclear Import of Phosphorylated STAT1

(ALSO SEE RELATED ARTICLES IN THE LINKS BELOW)